INM $7.5 target short term

NASDAQ:INM   InMed Pharmaceuticals Inc
First has to maintain the .236 fib at $4.71 for me to consider an entry, getting to $7.5+ shouldn't be a problem after that.

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.